MedTrace Logo

Study on Infectious Mononucleosis in Munich

NCT06002802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-02-07

No results posted yet for this study

Summary

This observational clinical study aims at the identification of novel biomarkers and causative factors of complicated and/or protracted Epstein-Barr virus-associated infectious mononucleosis (IM).

Clinical, biochemical, and routine virological data were collected from 200 patients with IM, novel analytical tools were implemented, and immunological and virological experimental data were generated using blood samples and mouthwashes. Patients have been investigated within four weeks after the onset of symptoms as well as one month and six months thereafter.

Conditions

  • Infectious Mononucleosis
  • Epstein-Barr Virus Infections

Sponsors & Collaborators

  • Helmholtz Zentrum München

    collaborator INDUSTRY

  • German Cancer Research Center

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • Hannover Medical School

    collaborator OTHER

  • University Hospital Freiburg

    collaborator OTHER

  • German Center for Infection Research

    collaborator OTHER

  • Technical University of Munich

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002802 on ClinicalTrials.gov